These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Adial Pharmaceuticals (ADIL), 2,010% surge in interest Alpine Immune
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Adial Pharmaceuticals (ADIL), 2,010% surge in interest Alpine Immune
Moderna (NASDAQ:MRNA) has postponed its plans to set up a vaccine manufacturing plant in Kenya, according to a Financial Times report. The biotech major had entered into a deal with
Modern has put plans to build a vaccine plant in Kenya on hold, a sign its move to invest in pandemic preparedness in Africa has dropped the agenda as COVID-19
Needham analyst Joseph Stringer has maintained their neutral stance on MRNA stock, giving a Hold rating on March 27. Joseph Stringer has given his Hold rating due to a combination
For a while, things weren’t looking all that great for biotech stock Moderna (NASDAQ:MRNA). Its primary stock in trade, the COVID-19 vaccine, has been falling off for years as the